SCHEMBL23540965

SCHEMBL23540965

O=c1[nH]c(=O)c2cc(Cl)c(Br)c(O)c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
IDH1 O75874 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
GRIN2D O15399 3/20 0.37
GRIN3B O60391 3/20 0.37
GRIN1 Q05586 3/20 0.37
GRIN2A Q12879 3/20 0.37
GRIN2B Q13224 3/20 0.37
GRIN2C Q14957 3/20 0.37
GRIN3A Q8TCU5 3/20 0.37
DAO P14920 4/20 0.33
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
LMNA P02545 2/20 0.33
PNP P00491 1/20 0.33
TYMP P19971 1/20 0.33
GDA Q9Y2T3 1/20 0.32
SERPINE1 P05121 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29947950 1.00 AR (0.41) ARIDH1CSNK2A2CSNK2BCSNK2A1
SCHEMBL25988754 0.84 IDH1 (0.39) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL25601009 0.83 IDH1 (0.38) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL30168669 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL29388927 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL23539934 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL16637455 0.81 IDH1 (0.36) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL24791176 0.81 GRIN2D (0.38) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D
SCHEMBL24790701 0.75 KDM4E (0.39) TYMPKDM4EALDH1A1HPGD
SCHEMBL7026627 0.75 IDH1 (0.35) IDH1CSNK2A2CSNK2BCSNK2A1GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-06-29 US disclosed
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. 2023-06-29 US disclosed
WO-2021127404-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. (US) 2021-06-24 WO disclosed
WO-2021127404-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES ERASCA, INC. (US) 2021-06-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203063-A1 TRICYCLIC PYRIDONES AND PYRIMIDONES TYMS, TYMP, DHFR AR 3850/4885IDH1 135/4885CSNK2A2 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.